These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. Norman B, Mahnke-Zizelman DK, Vallis A, Sabina RL. J Appl Physiol (1985); 1998 Oct; 85(4):1273-8. PubMed ID: 9760316 [Abstract] [Full Text] [Related]
24. Effect of creatine supplementation on physical performance are related to the AMPD1 and PPARG genes polymorphisms in football players. Lifanov D, Khadyeva MN, Rahmatullina LSh, Demenev SV, Ibragimov RR. Ross Fiziol Zh Im I M Sechenova; 2014 Jun; 100(6):767-76. PubMed ID: 25665401 [Abstract] [Full Text] [Related]
27. Does the C34T mutation in AMPD1 alter exercise capacity in the elderly? Pérez M, Martin MA, Cañete S, Rubio JC, Fernández-Moreira D, San Juan AF, Gómez-Gallego F, Santiago C, Arenas J, Lucia A. Int J Sports Med; 2006 Jun; 27(6):429-35. PubMed ID: 16767606 [Abstract] [Full Text] [Related]
28. Cardiac muscle AMP-deaminase from a 10-year-old male heterozygous for the AMPD1 C34T mutation. Rybakowska I, Bakuła S, Klimek J, Milczarek R, Smolenski RT, Kaletha K. Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):453-6. PubMed ID: 20544536 [Abstract] [Full Text] [Related]
30. The Association of Genetic Markers Involved in Muscle Performance Responding to Lactate Levels during Physical Exercise Therapy by Nordic Walking in Patients with Long COVID Syndrome: A Nonrandomized Controlled Pilot Study. Lizcano-Álvarez Á, Varillas-Delgado D, Cano-de-la-Cuerda R, Jiménez-Antona C, Melián-Ortiz A, Molero-Sánchez A, Laguarta-Val S. Int J Mol Sci; 2024 Jul 30; 25(15):. PubMed ID: 39125881 [Abstract] [Full Text] [Related]
32. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome). Gastmann A, Sigusch HH, Henke A, Reinhardt D, Surber R, Gastmann O, Figulla HR. Am J Cardiol; 2004 May 15; 93(10):1260-4. PubMed ID: 15135700 [Abstract] [Full Text] [Related]
33. FTO genotype is associated with exercise training-induced changes in body composition. Rankinen T, Rice T, Teran-Garcia M, Rao DC, Bouchard C. Obesity (Silver Spring); 2010 Feb 15; 18(2):322-6. PubMed ID: 19543202 [Abstract] [Full Text] [Related]
34. C34T mutation of the AMPD1 gene in an elite white runner. Lucia A, Martin MA, Esteve-Lanao J, San Juan AF, Rubio JC, Oliván J, Arenas J. Br J Sports Med; 2006 Mar 15; 40(3):e7. PubMed ID: 16505069 [Abstract] [Full Text] [Related]
35. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure. Kolek MJ, Carlquist JF, Thaneemit-Chen S, Lazzeroni LC, Whiting BM, Horne BD, Muhlestein JB, Lavori P, Anderson JL. J Card Fail; 2005 Dec 15; 11(9):677-83. PubMed ID: 16360962 [Abstract] [Full Text] [Related]
38. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. Anderson JL, Habashi J, Carlquist JF, Muhlestein JB, Horne BD, Bair TL, Pearson RR, Hart N. J Am Coll Cardiol; 2000 Oct 15; 36(4):1248-52. PubMed ID: 11028479 [Abstract] [Full Text] [Related]
39. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure. A study on 686 consecutive patients. de Groote P, Mouquet F, Dallongeville J, Lamblin N, Bauters C. Am Heart J; 2007 May 15; 153(5):e15. PubMed ID: 17452135 [No Abstract] [Full Text] [Related]
40. C34T AMP deaminase 1 gene mutation protects cardiac function in donors. Yacoub MH, Yuen AH, Kalsi KK, Birks EJ, Taegtmeyer A, Barton PJ, Johnson PH, Suzuki K, Smolenski RT. Transplantation; 2004 May 27; 77(10):1621-3. PubMed ID: 15239633 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]